-
Article
Open AccessModelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants
Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infections in children worldwide. The highest incidence of severe disease is in the first 6 months of life, with infants bo...
-
Article
Open AccessModelling the impact of hybrid immunity on future COVID-19 epidemic waves
Since the emergence of SARS-CoV-2 (COVID-19), there have been multiple waves of infection and multiple rounds of vaccination rollouts. Both prior infection and vaccination can prevent future infection and redu...
-
Article
Open AccessAuthor Correction: Develo** a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia
-
Article
Open AccessEstimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach
With the ongoing evolution of the SARS-CoV-2 virus updated vaccines may be needed. We fitted a model linking immunity levels and protection to vaccine effectiveness data from England for three vaccines (Oxford...
-
Article
Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS
To study the trade-off between economic, social and health outcomes in the management of a pandemic, DAEDALUS integrates a dynamic epidemiological model of SARS-CoV-2 transmission with a multi-sector economic ...
-
Article
Open AccessModelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic
Vaccine hesitancy – a delay in acceptance or refusal of vaccines despite availability – has the potential to threaten the successful roll-out of SARS-CoV-2 vaccines globally. In this study, we aim to understan...
-
Article
Open AccessDevelo** a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia
Respiratory syncytial virus (RSV) is a leading cause of childhood morbidity, however there is no systematic testing in children hospitalised with respiratory symptoms. Therefore, current RSV incidence likely u...
-
Article
Open AccessAnalysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
The RTS,S/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study seeks to identify whether vaccination could reach addit...
-
Article
Open AccessA Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of N...
-
Article
Open AccessHealth inequities and clustering of fever, acute respiratory infection, diarrhoea and wasting in children under five in low- and middle-income countries: a Demographic and Health Surveys analysis
Pneumonia, diarrhoea and malaria are responsible for over one third of all deaths in children under the age of 5 years in low and middle sociodemographic index countries; many of these deaths are also associat...
-
Article
Open AccessModelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Respiratory syncytial virus (RSV) infects almost all children by the age of 2 years, with the risk of hospitalisation highest in the first 6 months of life. Development and licensure of a vaccine to prevent se...
-
Article
The potential public health consequences of COVID-19 on malaria in Africa
The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and deaths associated with COVID-19 are rising1. In response, countries are implementing societal measures aimed at curtailing...
-
Article
Open AccessModelling population-level impact to inform target product profiles for childhood malaria vaccines
The RTS,S/AS01 vaccine for Plasmodium falciparum malaria demonstrated moderate efficacy in 5–17-month-old children in phase 3 trials, and from 2018, the vaccine will be evaluated through a large-scale pilot imple...
-
Article
A Model for the Spread of an Invasive Weed, Tradescantia fluminensis
Tradescantia fluminensis is an invasive weed and a serious threat to native forests in eastern Australia and New Zealand. Current methods of eradication are often ineffective, so understa...
-
Chapter and Conference Paper
Erratum to: Age Structures in Mathematical Models for Infectious Diseases, with a Case Study of Respiratory Syncytial Virus
-
Chapter and Conference Paper
Age Structures in Mathematical Models for Infectious Diseases, with a Case Study of Respiratory Syncytial Virus
Mathematical modelling plays an important role in understanding the dynamics of transmissible infections, as information about the drivers of infectious disease outbreaks can help inform health care planning a...
-
Chapter and Conference Paper
The Formation and Launch of the Asia Pacific Consortium of Mathematics for Industry (APCMfI)
The Forum “Math-for-Industry” 2014 (FMfI 2014) represented the first opportunity to formally showcase the concept and formation of the Asia Pacific Consortium of Mathematics for Industry (APCMfI). This new ini...
